These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL). Ottmann OG, Wassmann B, Pfeifer H, Giagounidis A, Stelljes M, Dührsen U, Schmalzing M, Wunderle L, Binckebanck A, Hoelzer D, GMALL Study Group. Cancer; 2007 May 15; 109(10):2068-76. PubMed ID: 17429836 [Abstract] [Full Text] [Related]
50. [Inefficiency of cisplatin and epidoxorubicin as a treatment in resistant adult acute lymphoblastic leukemia]. Avilés A, Rubio ME, Tripp F, González-Llavén J. Sangre (Barc); 1988 Dec 15; 33(6):522-4. PubMed ID: 3247627 [No Abstract] [Full Text] [Related]
51. Successful treatment of gastrointestinal mucormycosis in an adolescent with acute lymphoblastic leukaemia (ALL). Aabideen K, Lashkari HP, Holmes K, Taj M. Pediatr Blood Cancer; 2012 Feb 15; 58(2):312-3. PubMed ID: 21793182 [No Abstract] [Full Text] [Related]
53. Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86. Ludwig WD, Harbott J, Bartram CR, Komischke B, Sperling C, Teichmann JV, Seibt-Jung H, Notter M, Odenwald E, Nehmer A. Recent Results Cancer Res; 1993 Feb 15; 131():269-82. PubMed ID: 8210646 [No Abstract] [Full Text] [Related]
55. [Progress in the treatment of acute lymphoid leukemia in children. Experience of the GATLA/GLATHEM, 1967-1987]. Garay G, Aversa LA, Svarch E, Sackmann Muriel F, Drelichman G, Santarelli MT, Jiménez E, Divito JM, Pavlovsky S, Eppinger Helft M. Sangre (Barc); 1989 Apr 15; 34(2):136-43. PubMed ID: 2667171 [No Abstract] [Full Text] [Related]
56. Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON. Daenen S, van der Holt B, Dekker AW, Willemze R, Rijneveld AW, Biemond BJ, Muus P, van de Loosdrecht AA, Schouten HC, van Marwijk Kooy M, Breems DA, Demuynck H, Maertens J, Wijermans PW, Wittebol S, de Klerk EW, Cornelissen JJ, HOVON, Dutch-Belgian Cooperative Group for Hematological Oncology. Leukemia; 2012 Jul 15; 26(7):1726-9. PubMed ID: 22358264 [No Abstract] [Full Text] [Related]